Your session is about to expire
← Back to Search
Radiation Therapy + Rituximab for Follicular Lymphoma
Study Summary
This trial studies how well radiation therapy and rituximab work in treating patients with early stage follicular lymphoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have serious heart problems that need ongoing treatment.I do not have any active infections needing treatment.I've had radiation to the same area where my current cancer is, and can't have more without risking harm.I have an active hepatitis B or C infection.I am currently using alternative or complementary medicines.I have been newly diagnosed with early-stage follicular lymphoma, confirmed to be grade 1 or 2.My doctor decides if I need lamivudine to prevent hepatitis B.
- Group 1: Arm II (radiation therapy and observation)
- Group 2: Arm I (radiation therapy and rituximab)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What kind of medical applications does Rituximab have?
"Rituximab is a viable remedy for the treatment of dlbcl and additional illnesses, such as b-cell lymphomas, polyangium, or pemphigus vulgaris."
How many participants are included in the current research project?
"At this time, no new patients are being recruited for this particular trial. The opening of the study was on May 20th 2013 and it has since been updated on June 21st 2022. If you are seeking alternative trials, 1719 studies related to lymphoma, follicular are open at present with 406 trials using Rituximab still accepting participants."
Is registration open for this scientific investigation?
"Unfortunately, this clinical trial is not currently seeking enrolment. Even though it was initially posted in May 2013 and last updated in June 2022, there are still 1,719 trials actively recruiting people with lymphoma who need follicular treatments as well as 406 additional trials using Rituximab that require participants."
Share this study with friends
Copy Link
Messenger